The Bitcoiner’s Case for Government R&D
18
2
BTCCSquare news:
Government-funded research has long been a contentious topic, with critics arguing it crowds out private-sector innovation. Yet the data tells a different story. A 2015 study revealed that nearly every FDA-approved drug from 2010 to 2016 benefited from NIH support, with each $10 million in funding spurring two to three additional private-sector patents.
The economic returns are equally compelling. Congressional estimates suggest NIH grants deliver a 25% to 40% annual return by reducing healthcare costs—a compelling argument for public investment in scientific progress. While tech luminaries like Bezos or Altman may dominate headlines, these findings underscore government research's foundational role in technological advancement.
By:
Previous
Volkswagen Adopts Hivemapper’s Bee Maps for Autonomous Vehicle Testing
Next
ARI Wallet Offers Daily Quiz for Crypto Earnings
